サマリー

ヒト化マウスモデル市場 2024-2028
ヒト化マウスモデル市場は2023-2028年に1億860万米ドル成長し、予測期間中のCAGRは10.22%で加速すると予測される。この調査レポートは、ヒト化マウスモデル市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、個別化医療の採用拡大、ヒト化マウスモデルの革新的応用、遺伝子工学技術の進歩によって牽引されています。
Technavioのヒト化マウスモデル市場は以下のように区分される：
エンドユーザー別
- 製薬・バイオテクノロジー企業
- CRO
- 学術・研究機関
製品別
- 遺伝子組み換えヒト化マウスモデル
- 細胞ベースのヒト化マウスモデル
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、ベンダーの戦略的提携が、今後数年間のヒト化マウスモデル市場の成長を促進する主要な理由の1つであると特定している。また、MABの生産量の増加と全動物イメージングの出現は、市場の大きな需要につながる。
この調査レポートは、ヒト化マウスモデル市場を調査・分析した結果をまとめたものです：
- ヒト化マウスモデル市場のサイジング
- ヒト化マウスモデル市場予測
- ヒト化マウスモデル市場産業分析
本レポートでは、ヒト化マウスモデル市場の主要ベンダー（Altogen labs、Aragen Life Sciences Pvt. Ltd.、Biocytogen、BioSafety Research Center Inc.、Champions Oncology Inc.、Charles River Laboratories International Inc.、Creative Biolabs、Cyagen Biosciences、Gempharmatech Co.Ltd.、genOway、HBM Holdings Ltd.、Hera Biolabs Inc.、ingenious targeting laboratory、Inotiv, Inc.、JANVIER LABS、JSR Corp.、Oncodesign SA、Ozgene Pty Ltd.、PerkinElmer Inc.、Pharmatest services。また、ヒト化マウスモデル市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/humanized-mouse-model-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global humanized mouse model market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global humanized mouse model market 2018 - 2022 ($ million)
o 4.2 End-user Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
o 4.3 Product Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
o Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
o 6.2 Comparison by End-user
o Exhibit 32: Chart on Comparison by End-user
o Exhibit 33: Data Table on Comparison by End-user
o 6.3 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
o Exhibit 34: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
o 6.4 CROs - Market size and forecast 2023-2028
o Exhibit 38: Chart on CROs - Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on CROs - Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on CROs - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on CROs - Year-over-year growth 2023-2028 (%)
o 6.5 Academic and research institutions - Market size and forecast 2023-2028
o Exhibit 42: Chart on Academic and research institutions - Market size and forecast 2023-2028 ($ million)
o Exhibit 43: Data Table on Academic and research institutions - Market size and forecast 2023-2028 ($ million)
o Exhibit 44: Chart on Academic and research institutions - Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Academic and research institutions - Year-over-year growth 2023-2028 (%)
o 6.6 Market opportunity by End-user
o Exhibit 46: Market opportunity by End-user ($ million)
o Exhibit 47: Data Table on Market opportunity by End-user ($ million)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 48: Chart on Product - Market share 2023-2028 (%)
o Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
o 7.2 Comparison by Product
o Exhibit 50: Chart on Comparison by Product
o Exhibit 51: Data Table on Comparison by Product
o 7.3 Genetically humanized mouse model - Market size and forecast 2023-2028
o Exhibit 52: Chart on Genetically humanized mouse model - Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on Genetically humanized mouse model - Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on Genetically humanized mouse model - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Genetically humanized mouse model - Year-over-year growth 2023-2028 (%)
o 7.4 Cell-based humanized mouse model - Market size and forecast 2023-2028
o Exhibit 56: Chart on Cell-based humanized mouse model - Market size and forecast 2023-2028 ($ million)
o Exhibit 57: Data Table on Cell-based humanized mouse model - Market size and forecast 2023-2028 ($ million)
o Exhibit 58: Chart on Cell-based humanized mouse model - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Cell-based humanized mouse model - Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by Product
o Exhibit 60: Market opportunity by Product ($ million)
o Exhibit 61: Data Table on Market opportunity by Product ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 UK - Market size and forecast 2023-2028
o Exhibit 87: Chart on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.9 France - Market size and forecast 2023-2028
o Exhibit 91: Chart on France - Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on France - Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on France - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on France - Year-over-year growth 2023-2028 (%)
o 9.10 China - Market size and forecast 2023-2028
o Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.11 Japan - Market size and forecast 2023-2028
o Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Altogen labs
o Exhibit 111: Altogen labs - Overview
o Exhibit 112: Altogen labs - Product / Service
o Exhibit 113: Altogen labs - Key offerings
o 12.4 Aragen Life Sciences Pvt. Ltd.
o Exhibit 114: Aragen Life Sciences Pvt. Ltd. - Overview
o Exhibit 115: Aragen Life Sciences Pvt. Ltd. - Product / Service
o Exhibit 116: Aragen Life Sciences Pvt. Ltd. - Key news
o Exhibit 117: Aragen Life Sciences Pvt. Ltd. - Key offerings
o 12.5 Biocytogen
o Exhibit 118: Biocytogen - Overview
o Exhibit 119: Biocytogen - Product / Service
o Exhibit 120: Biocytogen - Key offerings
o 12.6 BioSafety Research Center Inc.
o Exhibit 121: BioSafety Research Center Inc. - Overview
o Exhibit 122: BioSafety Research Center Inc. - Product / Service
o Exhibit 123: BioSafety Research Center Inc. - Key offerings
o 12.7 Champions Oncology Inc.
o Exhibit 124: Champions Oncology Inc. - Overview
o Exhibit 125: Champions Oncology Inc. - Product / Service
o Exhibit 126: Champions Oncology Inc. - Key news
o Exhibit 127: Champions Oncology Inc. - Key offerings
o 12.8 Charles River Laboratories International Inc.
o Exhibit 128: Charles River Laboratories International Inc. - Overview
o Exhibit 129: Charles River Laboratories International Inc. - Business segments
o Exhibit 130: Charles River Laboratories International Inc. - Key news
o Exhibit 131: Charles River Laboratories International Inc. - Key offerings
o Exhibit 132: Charles River Laboratories International Inc. - Segment focus
o 12.9 Creative Biolabs
o Exhibit 133: Creative Biolabs - Overview
o Exhibit 134: Creative Biolabs - Product / Service
o Exhibit 135: Creative Biolabs - Key offerings
o 12.10 Cyagen Biosciences
o Exhibit 136: Cyagen Biosciences - Overview
o Exhibit 137: Cyagen Biosciences - Product / Service
o Exhibit 138: Cyagen Biosciences - Key offerings
o 12.11 Gempharmatech Co. Ltd.
o Exhibit 139: Gempharmatech Co. Ltd. - Overview
o Exhibit 140: Gempharmatech Co. Ltd. - Product / Service
o Exhibit 141: Gempharmatech Co. Ltd. - Key offerings
o 12.12 genOway
o Exhibit 142: genOway - Overview
o Exhibit 143: genOway - Product / Service
o Exhibit 144: genOway - Key offerings
o 12.13 HBM Holdings Ltd.
o Exhibit 145: HBM Holdings Ltd. - Overview
o Exhibit 146: HBM Holdings Ltd. - Product / Service
o Exhibit 147: HBM Holdings Ltd. - Key offerings
o 12.14 Hera Biolabs Inc.
o Exhibit 148: Hera Biolabs Inc. - Overview
o Exhibit 149: Hera Biolabs Inc. - Product / Service
o Exhibit 150: Hera Biolabs Inc. - Key offerings
o 12.15 ingenious targeting laboratory
o Exhibit 151: ingenious targeting laboratory - Overview
o Exhibit 152: ingenious targeting laboratory - Product / Service
o Exhibit 153: ingenious targeting laboratory - Key offerings
o 12.16 JSR Corp.
o Exhibit 154: JSR Corp. - Overview
o Exhibit 155: JSR Corp. - Business segments
o Exhibit 156: JSR Corp. - Key offerings
o Exhibit 157: JSR Corp. - Segment focus
o 12.17 PerkinElmer Inc.
o Exhibit 158: PerkinElmer Inc. - Overview
o Exhibit 159: PerkinElmer Inc. - Business segments
o Exhibit 160: PerkinElmer Inc. - Key news
o Exhibit 161: PerkinElmer Inc. - Key offerings
o Exhibit 162: PerkinElmer Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 163: Inclusions checklist
o Exhibit 164: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 165: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 166: Research methodology
o Exhibit 167: Validation techniques employed for market sizing
o Exhibit 168: Information sources
o 13.5 List of abbreviations
o Exhibit 169: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global humanized mouse model market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on End-user - Market share 2023-2028 (%)
Exhibits31: Data Table on End-user - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on CROs - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on CROs - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on CROs - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on CROs - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Academic and research institutions - Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Academic and research institutions - Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Academic and research institutions - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Academic and research institutions - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by End-user ($ million)
Exhibits47: Data Table on Market opportunity by End-user ($ million)
Exhibits48: Chart on Product - Market share 2023-2028 (%)
Exhibits49: Data Table on Product - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Product
Exhibits51: Data Table on Comparison by Product
Exhibits52: Chart on Genetically humanized mouse model - Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Genetically humanized mouse model - Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Genetically humanized mouse model - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Genetically humanized mouse model - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Cell-based humanized mouse model - Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Cell-based humanized mouse model - Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Cell-based humanized mouse model - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Cell-based humanized mouse model - Year-over-year growth 2023-2028 (%)
Exhibits60: Market opportunity by Product ($ million)
Exhibits61: Data Table on Market opportunity by Product ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2023 and 2028
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Altogen labs - Overview
Exhibits112: Altogen labs - Product / Service
Exhibits113: Altogen labs - Key offerings
Exhibits114: Aragen Life Sciences Pvt. Ltd. - Overview
Exhibits115: Aragen Life Sciences Pvt. Ltd. - Product / Service
Exhibits116: Aragen Life Sciences Pvt. Ltd. - Key news
Exhibits117: Aragen Life Sciences Pvt. Ltd. - Key offerings
Exhibits118: Biocytogen - Overview
Exhibits119: Biocytogen - Product / Service
Exhibits120: Biocytogen - Key offerings
Exhibits121: BioSafety Research Center Inc. - Overview
Exhibits122: BioSafety Research Center Inc. - Product / Service
Exhibits123: BioSafety Research Center Inc. - Key offerings
Exhibits124: Champions Oncology Inc. - Overview
Exhibits125: Champions Oncology Inc. - Product / Service
Exhibits126: Champions Oncology Inc. - Key news
Exhibits127: Champions Oncology Inc. - Key offerings
Exhibits128: Charles River Laboratories International Inc. - Overview
Exhibits129: Charles River Laboratories International Inc. - Business segments
Exhibits130: Charles River Laboratories International Inc. - Key news
Exhibits131: Charles River Laboratories International Inc. - Key offerings
Exhibits132: Charles River Laboratories International Inc. - Segment focus
Exhibits133: Creative Biolabs - Overview
Exhibits134: Creative Biolabs - Product / Service
Exhibits135: Creative Biolabs - Key offerings
Exhibits136: Cyagen Biosciences - Overview
Exhibits137: Cyagen Biosciences - Product / Service
Exhibits138: Cyagen Biosciences - Key offerings
Exhibits139: Gempharmatech Co. Ltd. - Overview
Exhibits140: Gempharmatech Co. Ltd. - Product / Service
Exhibits141: Gempharmatech Co. Ltd. - Key offerings
Exhibits142: genOway - Overview
Exhibits143: genOway - Product / Service
Exhibits144: genOway - Key offerings
Exhibits145: HBM Holdings Ltd. - Overview
Exhibits146: HBM Holdings Ltd. - Product / Service
Exhibits147: HBM Holdings Ltd. - Key offerings
Exhibits148: Hera Biolabs Inc. - Overview
Exhibits149: Hera Biolabs Inc. - Product / Service
Exhibits150: Hera Biolabs Inc. - Key offerings
Exhibits151: ingenious targeting laboratory - Overview
Exhibits152: ingenious targeting laboratory - Product / Service
Exhibits153: ingenious targeting laboratory - Key offerings
Exhibits154: JSR Corp. - Overview
Exhibits155: JSR Corp. - Business segments
Exhibits156: JSR Corp. - Key offerings
Exhibits157: JSR Corp. - Segment focus
Exhibits158: PerkinElmer Inc. - Overview
Exhibits159: PerkinElmer Inc. - Business segments
Exhibits160: PerkinElmer Inc. - Key news
Exhibits161: PerkinElmer Inc. - Key offerings
Exhibits162: PerkinElmer Inc. - Segment focus
Exhibits163: Inclusions checklist
Exhibits164: Exclusions checklist
Exhibits165: Currency conversion rates for US$
Exhibits166: Research methodology
Exhibits167: Validation techniques employed for market sizing
Exhibits168: Information sources
Exhibits169: List of abbreviations